Equine Partners America

Equine Partners America is a leading brand that specializes in providing cutting-edge technology to veterinarians, enabling them to enhance the well-being of horses and canines. The company is committed to improving the lives of these animals through their innovative products and services. One of their remarkable offerings is the Alpha2EQ Injection, which utilizes Astaria Global's patented Alpha2EQ system.

This revolutionary therapy process concentrates and isolates Alpha-2-Macroglobulin (A2M), a master protease inhibitor. By binding to proteases and halting tissue degradation, A2M plays a crucial role in preventing cartilage catabolism and further joint degradation. Unlike other blood products, Equine Partners America's Alpha2EQ Injection is unique because it employs specialized orthobiologic technology within the concentrated A2M molecule.

This technology allows patients to effectively clean out their joints, offering significant anti-inflammatory benefits. Moreover, the Alpha2EQ Injection is autologous, minimizing the risk of adverse side effects caused by drugs. With its potent and fast-acting anti-inflammatory properties, this injection is regarded as the most powerful option available.

Additionally, it provides excellent value for money, with a volume of 28-34 mL at only $15. 00/mL, surpassing other blood product offerings on the market. Equine Partners America has gained recognition for the longevity of their injection's effectiveness, providing lasting benefits for horses and canines.

To learn more and explore the scientific research supporting the Alpha2EQ system, visit their website or contact them to arrange a demonstration. Trust Equine Partners America to deliver top-notch solutions for regenerative medicine in the veterinary field